Lydicamycin
Lydicamycin is an antibiotic isolated from the fermentation broth of an actinomycete strain identified as Streptomyces lydicus. Lydicamycin is active against Gram-positive bacteria and a certain yeast, but inactive against Gram-negative bacteria[1].
Product Specifications
CAS Number
133352-27-9
UNSPSC
12352005
Target
Antibiotic; Bacterial
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/lydicamycin.html
Solubility
10 mM in DMSO
Smiles
N=C(N1C(CC(O)C/C=C(C)/C(O)C/C=C/C(O)C(C)/C=C/C(O)C/C=C(C)/C(O)C(C)CCC2C(C)(C(C3=C(O)CNC3=O)=O)C4CCC(O)C(O)C4C=C2C)CCC1)N
Molecular Formula
C47H74N4O10
Molecular Weight
855.11
References & Citations
[1]Hayakawa Y, et al. Lydicamycin, a new antibiotic of a novel skeletal type. I. Taxonomy, fermentation, isolation and biological activity. J Antibiot (Tokyo) . 1991;44 (3) :282-287.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
